Company Filing History:
Years Active: 2006
Title: Mary Ponsford: Innovator in Tolerogenic Peptides
Introduction
Mary Ponsford is a notable inventor based in Bristol, GB. She has made significant contributions to the field of immunology through her innovative research and development of peptides. Her work focuses on the therapeutic potential of myelin basic protein peptides.
Latest Patents
Mary Ponsford holds a patent for "Tolerogenic peptides from myelin basic protein." This patent describes a peptide capable of binding to an MHC class I or II molecule without further processing, known as an apitope. The patent specifically includes peptides selected from the region 131-158 of myelin basic protein, including sequences such as 134-148, 135-149, 136-150, 137-151, 138-152, 139-153, and 140-154. The patent also outlines the use of these peptides in pharmaceutical compositions and methods for treating or preventing diseases.
Career Highlights
Throughout her career, Mary has worked with Apitope Technology (Bristol) Limited and Apitope Technology Limited. Her innovative work has positioned her as a key figure in the development of therapeutic peptides.
Collaborations
Mary has collaborated with notable colleagues, including David Wraith and Heather Streeter. These collaborations have further advanced her research and contributed to the field of immunology.
Conclusion
Mary Ponsford's contributions to the development of tolerogenic peptides highlight her innovative spirit and dedication to advancing medical science. Her work continues to influence the field and offers promising avenues for future research and therapeutic applications.